Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for OMEGA THERAPEUTICS INC
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-09-14
Sale
2022-09-15
4:10 pm
Omega Therapeutics Inc. OMGA Young Richard A
Director
10,000 $8 $80,000 784,118
(Direct)
View
2021-08-03
Purchase
2021-08-05
5:43 pm
Omega Therapeutics Inc. OMGA Flagship Pioneering Inc.
Flagship Ventures Fund V General Partner LLC
Flagship V VentureLabs Rx Fund L.P.
Flagship Ventures Fund V L.P.
Flagship VentureLabs V Manager LLC
Flagship VentureLabs V LLC
10% Owner
1,176,469 $17 $19,999,973 3,814,705
(Indirect)
View
2021-08-03
Purchase
2021-08-05
5:41 pm
Omega Therapeutics Inc. OMGA Flagship Pioneering Inc.
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VI L.P.
Flagship Pioneering Special Opportunities Fund II L.P.
Flagship Pioneering Special Opportunities Fund II General Partner LLC
Nutritional Health LTP Fund L.P.
Nutritional Health LTP Fund General Partner LLC
FPN General Partner LLC
FPN L.P.
AFEYAN NOUBAR
10% Owner
1,176,469 $17 $19,999,973 3,814,705
(Indirect)
View
2021-08-03
Purchase
2021-08-03
5:16 pm
Omega Therapeutics Inc. OMGA Sawhney Roger
CFO
2,941 $17 $49,997 2,941
(Direct)
View
2021-07-30
Purchase
2021-08-03
5:16 pm
Omega Therapeutics Inc. OMGA Invus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Artal Treasury Ltd
Invus Public Equities Advisors LLC
10% Owner
950,000 $16.93 $16,085,343 2,273,530
(Direct)
View
2021-08-03
Purchase
2021-08-03
5:15 pm
Omega Therapeutics Inc. OMGA BERRY DAVID A
Director
53,082 $17 $902,394 53,082
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-10-27
Option Award
2022-10-28
6:43 pm
N/A
2032-10-26
Omega Therapeutics Inc. OMGA Karande Mahesh
CEO
170,000 $0 170,000
(Direct)
View
2022-10-27
Option Award
2022-10-28
6:40 pm
N/A
2032-10-26
Omega Therapeutics Inc. OMGA McCauley Thomas
Chief Scientific Officer
55,000 $0 55,000
(Direct)
View
2022-10-27
Option Award
2022-10-28
6:39 pm
N/A
2032-10-26
Omega Therapeutics Inc. OMGA Zeng Ling
See Remarks
55,000 $0 55,000
(Direct)
View
2022-10-27
Option Award
2022-10-28
6:39 pm
N/A
2032-10-26
Omega Therapeutics Inc. OMGA McManus Kevin
Chief Human Resources Officer
55,000 $0 55,000
(Direct)
View
2022-10-27
Option Award
2022-10-28
6:38 pm
N/A
2032-10-26
Omega Therapeutics Inc. OMGA Moore Yan
Chief Medical Officer
55,000 $0 55,000
(Direct)
View
2022-10-27
Option Award
2022-10-28
6:36 pm
N/A
2032-10-26
Omega Therapeutics Inc. OMGA Reed Joshua
CFO
55,000 $0 55,000
(Direct)
View
2022-08-31
Option Award
2022-09-01
4:27 pm
N/A
2032-08-30
Omega Therapeutics Inc. OMGA Boehm Rainer J.
Director
36,713 $0 36,713
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:10 pm
N/A
2032-06-07
Omega Therapeutics Inc. OMGA Levy Elliott M.
Director
18,118 $0 18,118
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:10 pm
N/A
2032-06-07
Omega Therapeutics Inc. OMGA MENDLEIN JOHN
Director
18,118 $0 18,118
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:10 pm
N/A
2032-06-07
Omega Therapeutics Inc. OMGA BESHAR LUKE M
Director
18,118 $0 18,118
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:10 pm
N/A
2032-06-07
Omega Therapeutics Inc. OMGA AFEYAN NOUBAR
Director
10% Owner
18,118 $0 18,118
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:10 pm
N/A
2032-06-07
Omega Therapeutics Inc. OMGA Young Richard A
Director
18,118 $0 18,118
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:10 pm
N/A
2032-06-07
Omega Therapeutics Inc. OMGA Szela Mary T
Director
18,118 $0 18,118
(Direct)
View
2022-05-31
Option Award
2022-06-02
6:51 pm
N/A
2032-05-30
Omega Therapeutics Inc. OMGA Reed Joshua
CFO
320,000 $0 320,000
(Direct)
View
2022-03-31
Option Award
2022-04-01
4:20 pm
N/A
2032-03-30
Omega Therapeutics Inc. OMGA McManus Kevin
Chief Human Resources Officer
125,000 $0 125,000
(Direct)
View
2022-03-31
Option Award
2022-04-01
4:20 pm
N/A
2032-03-30
Omega Therapeutics Inc. OMGA Zeng Ling
See Remarks
270,000 $0 270,000
(Direct)
View
2022-03-09
Option Award
2022-03-11
4:05 pm
N/A
2032-03-08
Omega Therapeutics Inc. OMGA Karande Mahesh
CEO
340,000 $0 340,000
(Direct)
View
2022-03-09
Option Award
2022-03-11
4:05 pm
N/A
2032-03-08
Omega Therapeutics Inc. OMGA McCauley Thomas
Chief Scientific Officer
110,000 $0 110,000
(Direct)
View
2022-03-09
Option Award
2022-03-11
4:05 pm
N/A
2032-03-08
Omega Therapeutics Inc. OMGA Sawhney Roger
CFO
60,000 $0 60,000
(Direct)
View
2022-02-01
Exercise
2022-02-03
4:05 pm
N/A
N/A
Omega Therapeutics Inc. OMGA Karande Mahesh
CEO
11,300 $0.53 1,001,782
(Direct)
View
2022-02-01
Exercise
2022-02-03
4:05 pm
N/A
2029-06-23
Omega Therapeutics Inc. OMGA Karande Mahesh
CEO
11,300 $0 1,001,782
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:05 pm
N/A
2032-01-30
Omega Therapeutics Inc. OMGA Moore Yan
Chief Medical Officer
477,715 $0 477,715
(Direct)
View
2021-08-03
Conversion
2021-08-05
5:43 pm
N/A
N/A
Omega Therapeutics Inc. OMGA Flagship Pioneering Inc.
Flagship Ventures Fund V General Partner LLC
Flagship V VentureLabs Rx Fund L.P.
Flagship Ventures Fund V L.P.
Flagship VentureLabs V Manager LLC
Flagship VentureLabs V LLC
10% Owner
107,637,306 $0 3,814,705
(Indirect)
View
2021-08-03
Conversion
2021-08-05
5:41 pm
N/A
N/A
Omega Therapeutics Inc. OMGA Flagship Pioneering Inc.
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VI L.P.
Flagship Pioneering Special Opportunities Fund II L.P.
Flagship Pioneering Special Opportunities Fund II General Partner LLC
Nutritional Health LTP Fund L.P.
Nutritional Health LTP Fund General Partner LLC
FPN General Partner LLC
FPN L.P.
AFEYAN NOUBAR
10% Owner
107,637,306 $0 3,814,705
(Indirect)
View
2021-07-30
Conversion
2021-08-03
5:16 pm
N/A
N/A
Omega Therapeutics Inc. OMGA Invus Public Equities L.P.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Artal Treasury Ltd
Invus Public Equities Advisors LLC
10% Owner
6,323,530 $0 2,273,530
(Direct)
View
2021-07-29
Option Award
2021-07-30
5:05 pm
N/A
2031-07-28
Omega Therapeutics Inc. OMGA AFEYAN NOUBAR
Director
10% Owner
19,852 $0 19,852
(Direct)
View
2021-07-29
Option Award
2021-07-30
5:05 pm
N/A
2031-07-28
Omega Therapeutics Inc. OMGA BESHAR LUKE M
Director
52,941 $0 52,941
(Direct)
View
2021-07-29
Option Award
2021-07-30
5:05 pm
N/A
2031-07-28
Omega Therapeutics Inc. OMGA BERRY DAVID A
Director
19,852 $0 19,852
(Direct)
View
2021-07-29
Ownership
2021-07-29
9:05 pm
N/A
N/A
Omega Therapeutics Inc. OMGA Flagship Pioneering Inc.
Flagship Ventures Fund V General Partner LLC
Flagship V VentureLabs Rx Fund L.P.
Flagship Ventures Fund V L.P.
Flagship VentureLabs V Manager LLC
Flagship VentureLabs V LLC
Director
10% Owner
0 $0 24,725,800
(Indirect)
View
2021-07-29
Ownership
2021-07-29
9:04 pm
N/A
2030-01-25
Omega Therapeutics Inc. OMGA MENDLEIN JOHN
Director
0 $0 221,360
(Direct)
View
2021-07-29
Ownership
2021-07-29
9:04 pm
N/A
2031-03-28
Omega Therapeutics Inc. OMGA Levy Elliott M.
Director
0 $0 52,941
(Direct)
View
2021-07-29
Ownership
2021-07-29
9:04 pm
N/A
N/A
Omega Therapeutics Inc. OMGA Young Richard A
Director
10% Owner
0 $0 794,118
(Direct)
View
2021-07-29
Ownership
2021-07-29
9:03 pm
N/A
2030-09-29
Omega Therapeutics Inc. OMGA Sawhney Roger
CFO
0 $0 499,681
(Direct)
View
Goto 0, 1, Next